Diagnosis and therapy of systemic candidiasis.

Systemic candidiasis is becoming a major obstacle in the care of debilitated patients, particularly those with primary or iatrogenically induced immune deficiencies. Successful management of this infection requires anticipatory surveillance of the potential victim, and correct interpretation of diagnostically significant signs and symptoms. Predisposing factors as well as clinical, mycological and serological findings that facilitate diagnosis are discussed in the light of 33 cases of systemic candidiasis observed by the authors.It is shown that timely treatment of candidemia raises the chances for survival from 20 to 80%. Toxic side and after effects of amphotericin B can be significantly minimized by holding the dosage to the minimum required to establish and maintain fungistatic serum levels of the drug and by judicious administration and spacing of the intravenous infusions. Guidelines for achieving these aims are presented.

[1]  P. Kozinn,et al.  Post mortem studies of systemic candidiasis: I. Diagnostic validity of precipitin reaction and probable origin of sensitization to cytoplasmic candidal antigens. , 1969, Sabouraudia.

[2]  D. Shurtleff.  Residua from systemic candidiasis treated with amphotericin. , 1968, The New England journal of medicine.

[3]  Seelig Ms.  The rationale for preventing antibacterial-induced fungal overgrowth. , 1968 .

[4]  J. Elkinton,et al.  Renal tubular acidosis due to amphotericin B. , 1968, The New England journal of medicine.

[5]  C. A. Ellis,et al.  [The significance of candidemia]. , 1967, Deutsche medizinische Wochenschrift.

[6]  A. González-Mendoza,et al.  Mycoses Dues a Des champignons opportunistes observées au cours de 1000 autopsies , 1967 .

[7]  R. G. Crounse,et al.  The relationship of transferrin and iron to serum inhibition of Candida albicans. , 1967, The Journal of investigative dermatology.

[8]  H. Zinneman,et al.  Bacteremia and Candida septicemia. Review of 185 cases during a four-year period. , 1967, Minnesota medicine.

[9]  D. Rifkind,et al.  Systemic fungal infections complicating renal transplantation and immunosuppressive therapy: Clinical, microbiologic, neurologic and pathologic features , 1967 .

[10]  P. Kozinn,et al.  Serodiagnosis of systemic candidiasis. , 1967, The Journal of infectious diseases.

[11]  Burry Hc.  Monilial septicaemia in acute leukaemia. Successful treatment in a case complicated by acute uric acid nephropathy. , 1966 .

[12]  D. Drutz,et al.  New approach to therapy with amphotericin B. , 1966, Antimicrobial agents and chemotherapy.

[13]  R. H. Levin,et al.  The nature and control of infections in patients with acute leukemia. , 1965, Cancer research.

[14]  G. Gherardi.  SYSTEMIC MONILIASIS IN INFANCY; FATAL RENAL HYPERTENSIVE COMPLICATIONS. , 1965, JAMA.

[15]  L. Haley,et al.  Yeast infections of the lower urinary tract. 1. In vitro studies of the tissue phase of Candida albicans. , 1965, Sabouraudia.

[16]  P. Kozinn,et al.  REVERSAL OF SERUM FUNGISTASIS BY ADDITION OF IRON. , 1964, The Journal of investigative dermatology.

[17]  H. I. Winner,et al.  Experimental renal moniliasis in the mouse. , 1963, The Journal of pathology and bacteriology.

[18]  P. Kozinn,et al.  Candida meningitis successfully treated with amphotericin B. , 1963, The New England journal of medicine.

[19]  F. Gloor,et al.  Endokarditis durch Candida parapsilosis , 1963 .

[20]  D. Louria,et al.  Disseminated moniliasis In the Adult. , 1962 .

[21]  Huter Rv,et al.  The occurrence of opportunistic fungus infections in a cancer hospital. , 1962 .

[22]  W. Roberts,et al.  Candida endocarditis. Clinical and pathologic studies. , 1962, The American journal of medicine.

[23]  Roberts Fb.  Recovery from monilial septicemia. , 1960 .